- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Drug utilization evaluation of anticancer drugs in a charitable hospital ; volume:40 ; number:01 ; year:2019 ; pages:105-110
Indian journal of medical & paediatric oncology ; 40, Heft 01 (2019), 105-110
- Beteiligte Personen und Organisationen
-
Mathew, Maneesha
Mateti, Uday Venkat
Saj, Neethu
Philip, Malona Lilly
Shetty, Vijith
- DOI
-
10.4103/ijmpo.ijmpo_156_18
- URN
-
urn:nbn:de:101:1-2021081213530198305737
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mathew, Maneesha
- Mateti, Uday Venkat
- Saj, Neethu
- Philip, Malona Lilly
- Shetty, Vijith
Ähnliche Objekte (12)
New anticancer drugs
Empagliflozin: a potential anticancer drug
CDK7 inhibitors as anticancer drugs
Neurological adverse reactions to anticancer drugs
Anticancer Drug Discovery: Role of Pharmacogenomics
Gold(III) compounds as anticancer drugs
Quantitative comparison of anticancer drug dispersal before and after introducing appropriate preparation procedures during anticancer drug preparation
Molecular aspects of anti-cancer drug action
Human tumour xenografts in anticancer drug development
Anticancer drug R&D landscape in China
Lignans: a versatile source of anticancer drugs
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
New anticancer drugs
Empagliflozin: a potential anticancer drug
CDK7 inhibitors as anticancer drugs
Neurological adverse reactions to anticancer drugs
Anticancer Drug Discovery: Role of Pharmacogenomics
Gold(III) compounds as anticancer drugs
Quantitative comparison of anticancer drug dispersal before and after introducing appropriate preparation procedures during anticancer drug preparation
Molecular aspects of anti-cancer drug action
Human tumour xenografts in anticancer drug development
Anticancer drug R&D landscape in China
Lignans: a versatile source of anticancer drugs
Genotypes Affecting the Pharmacokinetics of Anticancer Drugs
New anticancer drugs
Empagliflozin: a potential anticancer drug
CDK7 inhibitors as anticancer drugs
Neurological adverse reactions to anticancer drugs
Anticancer Drug Discovery: Role of Pharmacogenomics
Gold(III) compounds as anticancer drugs
Quantitative comparison of anticancer drug dispersal before and after introducing appropriate preparation procedures during anticancer drug preparation
Molecular aspects of anti-cancer drug action
Human tumour xenografts in anticancer drug development
Anticancer drug R&D landscape in China
Lignans: a versatile source of anticancer drugs